Histamine H3 receptor regulates sensorimotor gating and dopaminergic signaling in the striatum

Journal of Pharmacology and Experimental Therapeutics

Volumn 357, Issue 2, 2016, Pages 264-272

  Vanhanen, Jenni Kononoff ^a,b   Nuutinen, Saara ^a,b   Tuominen, Mervi ^a   Panula, Pertti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTIDINE DECARBOXYLASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENOTYPE; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY GATING; SIGNAL TRANSDUCTION; STARTLE REFLEX; WILD TYPE; ANIMAL; C57BL MOUSE; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; GENETICS; MOTOR ACTIVITY; PHYSIOLOGY;

ANIMALS; CORPUS STRIATUM; DOPAMINE AGENTS; DOPAMINERGIC NEURONS; HISTIDINE DECARBOXYLASE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H3; REFLEX, STARTLE; SENSORY GATING; SIGNAL TRANSDUCTION;

EID: 84963804482     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.115.230771     Document Type: Article

References (43)

1. Bello EP, Mateo Y, Gelman DM, Noaín D, Shin JH, Low MJ, Alvarez VA, Lovinger DM, and Rubinstein M (2011) Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci 14: 1033-1038.
2. Brabant C, Alleva L, Grisar T, Quertemont E, Lakaye B, Ohtsu H, Lin JS, Jatlow P, Picciotto MR, and Tirelli E (2009) Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions. Psychopharmacology (Berl) 202: 673-687.
3. Brami-Cherrier K, Valjent E, Garcia M, Pagès C, Hipskind RA, and Caboche J (2002) Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J Neurosci 22: 8911-8921.
4. Browman KE, Komater VA, Curzon P, Rueter LE, Hancock AA, Decker MW, and Fox GB (2004) Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behav Brain Res 153: 69-76.
5. Burban A, Sadakhom C, Dumoulin D, Rose C, Le Pen G, Frances H, and Arrang JM (2010) Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H3-receptor inverse agonists. Psychopharmacology (Berl) 210: 591-604.
6. Cai G, Zhen X, Uryu K, and Friedman E (2000) Activation of extracellular signalregulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats. J Neurosci 20: 1849-1857.
7. Castellan Baldan L, Williams KA, Gallezot JD, Pogorelov V, Rapanelli M, Crowley M, Anderson GM, Loring E, Gorczyca R, and Billingslea E, et al. (2014) Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron 81: 77-90.
8. Chen J, Rusnak M, Luedtke RR, and Sidhu A (2004) D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade. J Biol Chem 279: 39317-39330.
9. Dai H, Okuda T, Sakurai E, Kuramasu A, Kato M, Jia F, Xu AJ, Iinuma K, Sato I, and Yanai K (2005) Blockage of histamine H1 receptor attenuates social isolation-induced disruption of prepulse inhibition: a study in H1 receptor gene knockout mice. Psychopharmacology (Berl) 183: 285-293.
10. Ercan-Sencicek AG, Stillman AA, Ghosh AK, Bilguvar K, O'Roak BJ, Mason CE, Abbott T, Gupta A, King RA, and Pauls DL, et al. (2010) L-histidine decarboxylase and Tourette's syndrome. N Engl J Med 362: 1901-1908.
11. Fendt M, Li L, and Yeomans JS (2001) Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology (Berl) 156: 216-224.
12. Ferrada C, Ferré S, Casadó V, Cortés A, Justinova Z, Barnes C, Canela EI, Goldberg SR, Leurs R, and Lluis C, et al. (2008) Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 55: 190-197.
13. Ferrada C, Moreno E, Casadó V, Bongers G, Cortés A, Mallol J, Canela EI, Leurs R, Ferré S, and Lluís C, et al. (2009) Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br J Pharmacol 157: 64-75.
14. Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, and Komater VA, et al. (2005) Pharmacological properties of ABT-239 [4-(2-2-[(2R)-2-Methylpyrrolidinyl]ethyl-benzofuran-5-yl) benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 313: 176-190.
15. Goodchild RE, Court JA, Hobson I, Piggott MA, Perry RH, Ince P, Jaros E, and Perry EK (1999) Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases. Eur J Neurosci 11: 449-456.
16. Inoue I, Yanai K, Kitamura D, Taniuchi I, Kobayashi T, Niimura K, Watanabe T, and Watanabe T (1996) Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA 93: 13316-13320.
17. Kuhne S, Wijtmans M, Lim HD, Leurs R, and de Esch IJ (2011) Several down, a few to go: histamine H3 receptor ligands making the final push towards the market? Expert Opin Investig Drugs 20: 1629-1648.
18. Leppä E, Linden AM, Vekovischeva OY, Swinny JD, Rantanen V, Toppila E, Höger H, Sieghart W, Wulff P, and Wisden W, et al. (2011) Removal of GABA(A) receptor g2 subunits from parvalbumin neurons causes wide-ranging behavioral alterations. PLoS One 6: e24159.
19. Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, Robert P, Parmentier R, Anaclet C, and Lin JS, et al. (2007) Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73: 1215-1224.
20. Lintunen M, Sallmen T, Karlstedt K, Fukui H, Eriksson KS, and Panula P (1998) Postnatal expression of H1-receptor mRNA in the rat brain: correlation to L-histidine decarboxylase expression and local upregulation in limbic seizures. Eur J Neurosci 10: 2287-2301.
21. Mohr D, Pilz PK, Plappert CF, and Fendt M (2007) Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice. Neuroreport 18: 1493-1497.
22. Moreno E, Hoffmann H, Gonzalez-Sepúlveda M, Navarro G, Casadó V, Cortés A, Mallol J, Vignes M, McCormick PJ, and Canela EI, et al. (2011) Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem 286: 5846-5854.
23. Morisset S, Traiffort E, Arrang JM, and Schwartz JC (2000) Changes in histamine H3 receptor responsiveness in mouse brain. J Neurochem 74: 339-346.
24. Nuutinen S, Karlstedt K, Aitta-Aho T, Korpi ER, and Panula P (2010) Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice. Psychopharmacology (Berl) 208: 75-86.
25. Nuutinen S, Lintunen M, Vanhanen J, Ojala T, Rozov S, and Panula P (2011a) Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice. Neuropsychopharmacology 36: 2030-2040.
26. Nuutinen S, Vanhanen J, Pigni MC, and Panula P (2011b) Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA/2J mice. Neuropharmacology 60: 1193-1199.
27. Ohtsu H, Kuramasu A, Suzuki S, Igarashi K, Ohuchi Y, Sato M, Tanaka S, Nakagawa S, Shirato K, and Yamamoto M, et al. (1996) Histidine decarboxylase expression in mouse mast cell line P815 is induced by mouse peritoneal cavity incubation. J Biol Chem 271: 28439-28444.
28. Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G, Tchougounova E, Hellman L, Gertsenstein M, and Hirasawa N, et al. (2001) Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 502: 53-56.
29. Panula P, Flügge G, Fuchs E, Pirvola U, Auvinen S, and Airaksinen MS (1989) Histamine-immunoreactive nerve fibers in the mammalian spinal cord. Brain Res 484: 234-239.
30. Panula P and Nuutinen S (2013) The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 14: 472-487.
31. Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, and Arrang JM (2002) A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 114: 173-193.
32. Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, and Wyatt RJ (1995) Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 14: 93-104.
33. 3 receptor antagonist/inverse agonist with cognition-enhancing and wake-promoting activities. J Pharmacol Exp Ther 340: 124-133.
34. Ralph-Williams RJ, Lehmann-Masten V, and Geyer MA (2003) Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice. Neuropsychopharmacology 28: 108-118.
35. Ralph-Williams RJ, Lehmann-Masten V, Otero-Corchon V, Low MJ, and Geyer MA (2002) Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. J Neurosci 22: 9604-9611.
36. Roegge CS, Perraut C, Hao X, and Levin ED (2007) Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine. Pharmacol Biochem Behav 86: 686-692.
37. Swerdlow NR (2013) Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Neurosci Biobehav Rev 37: 1150-1156.
38. Swerdlow NR, Weber M, Qu Y, Light GA, and Braff DL (2008) Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 199: 331-388.
39. Vanhanen J, Kinnunen M, Nuutinen S, and Panula P (2015) Histamine H3 receptor antagonist JNJ-39220675 modulates locomotor responses but not place conditioning by dopaminergic drugs. Psychopharmacology (Berl) 232: 1143-1153.
40. 3 receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation. Br J Pharmacol 170: 177-187.
41. Wang C, Buck DC, Yang R, Macey TA, and Neve KA (2005) Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases. J Neurochem 93: 899-909.
42. Wieland K, Bongers G, Yamamoto Y, Hashimoto T, Yamatodani A, Menge WM, Timmerman H, Lovenberg TW, and Leurs R (2001) Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists. J Pharmacol Exp Ther 299: 908-914.
43. Yan Z, Feng J, Fienberg AA, and Greengard P (1999) D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc Natl Acad Sci USA 96: 11607-11612.